Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Customers Bancorp
CUBI
$2.83B
| $5.58M | ﹤0.01% |
85,348
+13,368
| +19% | +$734K |
|
1627
WesBanco
WSBC
$4.06B
| $5.56M | ﹤0.01% |
158,827
+49,763
| +46% | +$1.75M |
|
1628
National Vision
EYE
$1.85B
| $5.55M | ﹤0.01% |
115,734
+21,690
| +23% | +$1.16M |
|
|
CWEN.A
1629
DELISTED
Clearway Energy Class A
CWEN.A
| $5.54M | ﹤0.01% |
165,547
+43,023
| +35% | +$1.41M |
|
1630
Lakeland Financial Corp
LKFN
$1.58B
| $5.54M | ﹤0.01% |
69,131
+31,388
| +83% | +$2.34M |
|
1631
ArcBest
ARCB
$3.23B
| $5.53M | ﹤0.01% |
46,157
+17,634
| +62% | +$1.79M |
|
1632
Bank of Hawaii
BOH
$3.19B
| $5.52M | ﹤0.01% |
65,904
-22,387
| -25% | -$1.88M |
|
|
CCXI
1633
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.51M | ﹤0.01% |
151,216
+22,867
| +18% | +$803K |
|
1634
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
| $5.5M | ﹤0.01% |
153,800
-1,600,000
| -91% | -$54M |
|
1635
Shake Shack
SHAK
$2.67B
| $5.5M | ﹤0.01% |
76,253
+3,495
| +5% | +$266K |
|
|
AIMC
1636
DELISTED
Altra Industrial Motion Corp
AIMC
| $5.49M | ﹤0.01% |
106,525
+49,227
| +86% | +$2.7M |
|
1637
CALL
Pool Corp
POOL
$7.39B
| $5.49M | ﹤0.01% |
+9,700
| New | +$5.08M |
|
1638
Stepan Co
SCL
$1.45B
| $5.47M | ﹤0.01% |
44,012
+10,270
| +30% | +$1.24M |
|
1639
Element Solutions
ESI
$9.48B
| $5.47M | ﹤0.01% |
225,167
+213,140
| +1,772% | +$5.03M |
|
|
PDM
1640
Piedmont Realty Trust
PDM
$1.21B
| $5.45M | ﹤0.01% |
296,544
+28,710
| +11% | +$526K |
|
1641
HF Sinclair
DINO
$15.7B
| $5.44M | ﹤0.01% |
166,090
-128,887
| -44% | -$4.34M |
|
1642
Celsius Holdings
CELH
$7.55B
| $5.44M | ﹤0.01% |
218,931
-83,877
| -28% | -$2.32M |
|
1643
Sonic Automotive
SAH
$2.79B
| $5.44M | ﹤0.01% |
109,979
+59,560
| +118% | +$2.98M |
|
1644
CALL
Arista Networks
ANET
$240B
| $5.43M | ﹤0.01% |
+151,200
| New | +$4.51M |
|
1645
Graphic Packaging
GPK
$3.52B
| $5.42M | ﹤0.01% |
278,046
-335,095
| -55% | -$6.71M |
|
1646
Credit Acceptance
CACC
$6.15B
| $5.41M | ﹤0.01% |
7,863
-1,026
| -12% | -$660K |
|
1647
Celldex Therapeutics
CLDX
$3.07B
| $5.41M | ﹤0.01% |
139,952
+100,184
| +252% | +$4.37M |
|
1648
Dillards
DDS
$9.65B
| $5.4M | ﹤0.01% |
22,052
+864
| +4% | +$227K |
|
|
ITCI
1649
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.39M | ﹤0.01% |
102,970
+57,867
| +128% | +$2.43M |
|
1650
Denali Therapeutics
DNLI
$3.84B
| $5.39M | ﹤0.01% |
120,821
+49,856
| +70% | +$2.36M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.